NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS, INC. -- SCHEDULE 13D/A(

Company

Trevi Therapeutics, Inc.

Filed

November 8, 2024

Accession Number

0001072613-24-000813